Pharmaceutical companies navigate FDA regulations and explore AI solutions to enhance compliance in drug advertising and enforcement.In this Pharmacy Times interview, Edgar Asebey, Esq., FDA regulatory attorney at Frier Levitt, discusses how artificial intelligence (AI) could transform FDA enforcement and oversight of direct-to-consumer (DTC) advertising. He explains that as pharmaceutical advertising budgets have surged since […]
